Anglogold Ashanti Stock Hits New 52-Week Low (AU)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Anglogold Ashanti (NYSE: AU) hit a new 52-week low Thursday as it is currently trading at $17.34, below its previous 52-week low of $17.45 with 361,983 shares traded as of 9:36 a.m. ET. Average volume has been 2.5 million shares over the past 30 days.

Anglogold Ashanti has a market cap of $6.98 billion and is part of the basic materials sector and metals & mining industry. Shares are down 42.2% year to date as of the close of trading on Wednesday.

AngloGold Ashanti Limited engages in the exploration, production, and marketing of gold. It also produces by-products, such as silver, uranium, and sulfuric acid. The company has a P/E ratio of 11.3, below the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Anglogold Ashanti as a hold. The company's strengths can be seen in multiple areas, such as its reasonable valuation levels, expanding profit margins and notable return on equity. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, weak operating cash flow and generally higher debt management risk. You can view the full Anglogold Ashanti Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

President Trump Has Become 'Something of an Albatross' to the Stock Market, Jim Cramer Says

President Trump Has Become 'Something of an Albatross' to the Stock Market, Jim Cramer Says

Apple Should Buy This Healthcare Disruptor, Citi Analyst Says